leisure time -WSS

leisure time

author：explore 2025-10-02 19:20:14 - browse：48

James Comer -- coverage from STAT — Rep. James Comer, chair of the House Oversight Committee Kevin Dietsch/Getty Images

WASHINGTON — Congress wants to reform PBM business practices to help lower the cost of medicines — but don’t think they’ve forgotten drugmakers have a role in high drug prices.

Two lawmakers, including a Republican, questioned PhRMA Chief Operating Officer Lori Reilly about just how much her group was spending on its major campaigns against PBMs this year. Both Reps. Summer Lee (D-Pa.) and Eric Burlison (R-Mo.) used their time to question drugmakers over their spending on lawsuits against Medicare drug price negotiation and ad campaigns against pharmacy benefit managers.

Although Lee started off bashing PBMs for the fees they charge drugmakers, she quickly aimed her fire back on pharma. She said brand drugmakers charge Americans double what they charge other countries, and she asked why several drugmakers are suing the federal government over Medicare’s drug price negotiation.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： BioMarin wins approval for gene therapy to treat hemophilia A
Next article： How to fix the rural physician shortage in the U.S.

leisure time

knowledge

WSS

Congress gives doctors Medicare pay bump

Medical device lobby: We're tired of waiting on Medicare coverage

Readout Newsletter: Wegovy, dialysis, Humira, Vir, and more

How to fix the rural physician shortage in the U.S.

FogPharma raises $145 million in rare Series E round

NIH study of ME/CFS points to clear biological hallmarks

Wikipedia

leisure time

knowledge

Walensky prepares to leave CDC — and Congress — behind

Kale crackers and hibiscus tea: My five days on a 'fasting diet'

Wildfire smoke exposes gaps in outdoor worker protections

Abortion pill mifepristone to soon be dispensed at CVS, Walgreens

How to save PrEP access — and even expand it

Why getting cancer drugs just got harder for rural patients

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Readout Newsletter: Wegovy, dialysis, Humira, Vir, and more

Anesthesiologist group: stop taking Ozempic before surgery

Alabama IVF ruling threatens families facing fatal genetic disease

hotspot

Readout Newsletter: Alnylam, Celldex, Roche, Zealand Pharma

PBM reform efforts get punted in Congress

A solution to the after

New documents shed light on MD Anderson Cancer Institute feud

FDA does about

With competition flaring, obesity drug hits goal in liver disease study

knowledge

leisure time

knowledge

focus